Tag Archives: Raju Prasad
William Blair Keeps Their Buy Rating on Assembly Biosciences (ASMB)
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Assembly Biosciences (ASMB – Research Report). The company’s shares closed last Monday at $9.31, close to its 52-week low of $9.08. According to TipRanks.com, Prasad
Bluebird Bio (BLUE) Receives a Hold from William Blair
William Blair analyst Raju Prasad maintained a Hold rating on Bluebird Bio (BLUE – Research Report) today. The company’s shares closed last Monday at $107.04. According to TipRanks.com, Prasad is a 5-star analyst with an average return of 14.4% and
William Blair Sticks to Their Buy Rating for Celyad (CYAD)
William Blair analyst Raju Prasad maintained a Buy rating on Celyad (CYAD – Research Report) today. The company’s shares closed last Monday at $14.02. Prasad commented: “We view the enhanced product potency and persistence favorably and believe the proof-of-concept preliminary
Krystal Biotech Inc (KRYS) Receives a Buy from William Blair
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Krystal Biotech Inc (KRYS – Research Report). The company’s shares closed last Monday at $42.20. According to TipRanks.com, Prasad is a 4-star analyst with an
William Blair Keeps Their Buy Rating on Celyad (CYAD)
In a report released today, Raju Prasad from William Blair maintained a Buy rating on Celyad (CYAD – Research Report). The company’s shares closed last Monday at $12.54, close to its 52-week low of $10.19. Prasad commented: “We believe that
William Blair Keeps a Buy Rating on Rocket Pharmaceuticals Inc (RCKT)
William Blair analyst Raju Prasad maintained a Buy rating on Rocket Pharmaceuticals Inc (RCKT – Research Report) today. The company’s shares closed last Monday at $11.72, close to its 52-week low of $10.75. According to TipRanks.com, Prasad is a 4-star
